Susquehanna International Group’s Mersana Therapeutics MRSN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $133K | Buy |
17,975
+8,332
| +86% | +$61.7K | ﹤0.01% | 5777 |
|
|
2025
Q1 | $83K | Buy |
9,643
+7,649
| +384% | +$65.8K | ﹤0.01% | 5917 |
|
|
2024
Q4 | $71.3K | Sell |
1,994
-998
| -33% | -$35.7K | ﹤0.01% | 5782 |
|
|
2024
Q3 | $141K | Sell |
2,992
-1,362
| -31% | -$64.4K | ﹤0.01% | 4980 |
|
|
2024
Q2 | $219K | Buy |
4,354
+535
| +14% | +$26.9K | ﹤0.01% | 4625 |
|
|
2024
Q1 | $428K | Sell |
3,819
-2,292
| -38% | -$257K | ﹤0.01% | 3744 |
|
|
2023
Q4 | $354K | Sell |
6,111
-1,123
| -16% | -$65.1K | ﹤0.01% | 4329 |
|
|
2023
Q3 | $230K | Sell |
7,234
-4,459
| -38% | -$142K | ﹤0.01% | 4362 |
|
|
2023
Q2 | $962K | Buy |
11,693
+722
| +7% | +$59.4K | ﹤0.01% | 2768 |
|
|
2023
Q1 | $1.13M | Buy |
10,971
+9,373
| +587% | +$963K | ﹤0.01% | 2724 |
|
|
2022
Q4 | $234K | Sell |
1,598
-2,499
| -61% | -$366K | ﹤0.01% | 4261 |
|
|
2022
Q3 | $692K | Buy |
4,097
+3,333
| +436% | +$563K | ﹤0.01% | 3066 |
|
|
2022
Q2 | $88K | Sell |
764
-6,187
| -89% | -$713K | ﹤0.01% | 5053 |
|
|
2022
Q1 | $693K | Buy |
6,951
+2,073
| +42% | +$207K | ﹤0.01% | 3291 |
|
|
2021
Q4 | $759K | Buy |
4,878
+1,128
| +30% | +$176K | ﹤0.01% | 3219 |
|
|
2021
Q3 | $884K | Sell |
3,750
-674
| -15% | -$159K | ﹤0.01% | 2929 |
|
|
2021
Q2 | $1.5M | Sell |
4,424
-831
| -16% | -$282K | ﹤0.01% | 2418 |
|
|
2021
Q1 | $2.13M | Buy |
5,255
+4,729
| +899% | +$1.91M | ﹤0.01% | 2056 |
|
|
2020
Q4 | $350K | Sell |
526
-2,248
| -81% | -$1.5M | ﹤0.01% | 3747 |
|
|
2020
Q3 | $1.29M | Buy |
2,774
+1,763
| +174% | +$820K | ﹤0.01% | 1905 |
|
|
2020
Q2 | $591K | Buy |
1,011
+292
| +41% | +$171K | ﹤0.01% | 2751 |
|
|
2020
Q1 | $105K | Buy |
+719
| New | +$105K | ﹤0.01% | 4034 |
|
|
2019
Q4 | – | Sell |
-655
| Closed | -$26K | – | 4513 |
|
|
2019
Q3 | $26K | Sell |
655
-862
| -57% | -$34.2K | ﹤0.01% | 4267 |
|
|
2019
Q2 | $154K | Buy |
+1,517
| New | +$154K | ﹤0.01% | 4008 |
|